Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - Deferred ChargesAmortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Cellebrite DI (CLBT) EPS (Basic): 2019-2024

Historic EPS (Basic) for Cellebrite DI (CLBT) over the last 6 years, with Dec 2024 value amounting to -$1.35.

  • Cellebrite DI's EPS (Basic) rose 108.07% to $0.08 in Q3 2025 from the same period last year, while for Sep 2025 it was $0.33, marking a year-over-year increase of 120.87%. This contributed to the annual value of -$1.35 for FY2024, which is 213.95% down from last year.
  • As of FY2024, Cellebrite DI's EPS (Basic) stood at -$1.35, which was down 213.95% from -$0.43 recorded in FY2023.
  • In the past 5 years, Cellebrite DI's EPS (Basic) ranged from a high of $0.64 in FY2022 and a low of -$1.35 during FY2024.
  • Over the past 3 years, Cellebrite DI's median EPS (Basic) value was -$0.43 (recorded in 2023), while the average stood at -$0.38.
  • As far as peak fluctuations go, Cellebrite DI's EPS (Basic) surged by 712.50% in 2021, and later plummeted by 213.95% in 2024.
  • Cellebrite DI's EPS (Basic) (Yearly) stood at -$0.08 in 2020, then spiked by 712.50% to $0.49 in 2021, then soared by 30.61% to $0.64 in 2022, then tumbled by 167.19% to -$0.43 in 2023, then slumped by 213.95% to -$1.35 in 2024.